Currently, there are 960.00M common shares owned by the public and among those 730.44M shares have been available to trade.
The company’s stock has a 5-day price change of -13.26% and 13.47% over the past three months. RIVN shares are trading -50.09% year to date (YTD), with the 12-month market performance down to -47.72% lower. It has a 12-month low price of $8.26 and touched a high of $24.87 over the same period. RIVN has an average intraday trading volume of 39.95 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -13.54%, -20.14%, and -15.84% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Rivian Automotive Inc (NASDAQ: RIVN) shares accounts for 47.57% of the company’s 960.00M shares outstanding.
It has a market capitalization of $11.81B and a beta (3y monthly) value of 2.07. The earnings-per-share (ttm) stands at -$5.95. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.00% over the week and 5.84% over the month.
Earnings per share for the fiscal year are expected to increase by 15.39%, and 30.73% over the next financial year. EPS should grow at an annualized rate of 0.67% over the next five years, compared to -86.59% over the past 5-year period.
Looking at the support for the RIVN, a number of firms have released research notes about the stock. Deutsche Bank stated their Hold rating for the stock in a research note on September 10, 2024, with the firm’s price target at $14. Needham was of a view on June 28, 2024 that the stock is Buy, while Wedbush gave the stock Outperform rating on June 26, 2024, issuing a price target of $15- $20. Cantor Fitzgerald on their part issued Overweight rating on June 26, 2024.
